Arcosa, Inc. (NYSE:ACA – Get Free Report) has received a consensus rating of “Moderate Buy” from the six research firms that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation, three have given a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $138.3333.
ACA has been the topic of several research reports. Oppenheimer initiated coverage on Arcosa in a research report on Thursday, May 28th. They issued an “outperform” rating and a $150.00 target price on the stock. Barclays upped their target price on Arcosa from $115.00 to $140.00 and gave the company an “overweight” rating in a research report on Monday, May 4th. Weiss Ratings downgraded Arcosa from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, May 11th. Texas Capital raised Arcosa to a “strong-buy” rating in a research report on Friday, March 27th. Finally, Wall Street Zen raised Arcosa from a “sell” rating to a “hold” rating in a research report on Saturday, May 30th.
View Our Latest Stock Report on ACA
Arcosa Price Performance
Arcosa (NYSE:ACA – Get Free Report) last posted its earnings results on Thursday, April 30th. The company reported $0.51 EPS for the quarter, beating the consensus estimate of $0.13 by $0.38. Arcosa had a return on equity of 8.52% and a net margin of 7.88%.The company had revenue of $571.70 million for the quarter, compared to the consensus estimate of $642.40 million. During the same quarter in the prior year, the business earned $0.49 earnings per share. The firm’s revenue for the quarter was up 5.0% on a year-over-year basis. Equities research analysts expect that Arcosa will post 4.25 EPS for the current year.
Arcosa Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Wednesday, July 15th will be paid a $0.05 dividend. This represents a $0.20 annualized dividend and a dividend yield of 0.1%. The ex-dividend date is Wednesday, July 15th. Arcosa’s payout ratio is 4.42%.
Institutional Investors Weigh In On Arcosa
Institutional investors have recently made changes to their positions in the stock. State of Wyoming bought a new stake in shares of Arcosa in the first quarter valued at approximately $30,000. GHP Investment Advisors Inc. bought a new stake in shares of Arcosa in the first quarter valued at approximately $32,000. Farther Finance Advisors LLC boosted its stake in shares of Arcosa by 73.4% in the fourth quarter. Farther Finance Advisors LLC now owns 307 shares of the company’s stock valued at $33,000 after buying an additional 130 shares during the period. Bessemer Group Inc. boosted its stake in shares of Arcosa by 47.8% in the third quarter. Bessemer Group Inc. now owns 368 shares of the company’s stock valued at $35,000 after buying an additional 119 shares during the period. Finally, Quarry LP boosted its stake in shares of Arcosa by 160.0% in the third quarter. Quarry LP now owns 403 shares of the company’s stock valued at $38,000 after buying an additional 248 shares during the period. 90.66% of the stock is currently owned by institutional investors.
Arcosa Company Profile
Arcosa, Inc (NYSE: ACA) is a Dallas‐based industrial company that was formed through the spin‐off of Trinity Industries’ construction products business in 2018. Since its inception, Arcosa has focused on the manufacture and sale of critical infrastructure components, serving a diverse set of end markets including transportation, construction and energy.
The company’s Construction Products segment produces a broad range of highway safety products, such as guardrail systems, sign supports and crash cushions, as well as aggregates and ready‐mix concrete.
Recommended Stories
- Five stocks we like better than Arcosa
- 3 Retail Winners Using Cash Flow to Stay Ahead
- 3 Tech ETFs That Could Bounce Back After the AI Selloff
- 3 Penny Stocks Under $5 Backed by Real Revenue Growth
- 3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend
Receive News & Ratings for Arcosa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcosa and related companies with MarketBeat.com's FREE daily email newsletter.
